Calidi Biotherapeutics Inc. Revenue 2022–2022
Calidi Biotherapeutics Inc. annual/quarterly revenue history and growth rate from 2022 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Calidi Biotherapeutics Inc. annual revenue for 2022 was 45000.
No data available.
Calidi Biotherapeutics Inc. (CLDI) — Frequently Asked Questions
Calidi Biotherapeutics Inc. (CLDI) is a publicly traded US company. It has a market capitalization of $1M. In fiscal 2022 it reported revenue of $45,000 and net income of -$25M. Explore CLDI's stock price, financial statements, earnings history, margins and key ratios below.
What is Calidi Biotherapeutics Inc.'s market cap?
Calidi Biotherapeutics Inc. (CLDI) has a market capitalization of $1M.
What is the CLDI stock price?
CLDI trades at $0.17 (-3.26% on the day).
How much revenue does Calidi Biotherapeutics Inc. make?
Calidi Biotherapeutics Inc. reported revenue of $45,000 in fiscal 2022.
Is CLDI profitable?
In fiscal 2022, Calidi Biotherapeutics Inc. reported net income of -$25M.